Fetal Penile Length and Corpus Cavernosum Length - Normal Measurement Via Ultrasound
NCT ID: NCT01114867
Last Updated: 2014-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
200 participants
OBSERVATIONAL
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Change of Penile Corpus Cavernosum After Caudal Block Using Ultrasonography in Children
NCT02345785
The Role of "Hypospadias Objective Scoring Evaluation" (HOSE) and Uroflowmetry in Evaluation of Successful Hypospadias Repair
NCT05032222
Comparison Between the Clinical Assessment of the Undescended Testis and Its' Ultrasonographic Size
NCT02731989
Long Term Follow-up for Hypospadias
NCT04142632
Learning to Palpate the Child's Testicles Using Simulation
NCT07106502
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* routine ultrasound not preformed for anomalies at the genitourinary system,
* estimated fetal weight corresponds to gestational age.
Exclusion Criteria
* women who's fetuses are suspected to be with genitourinary anomaly.
14 Weeks
34 Weeks
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tel-Aviv Sourasky Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sorasky Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yoseph Hartoov, Dr
Role: PRINCIPAL_INVESTIGATOR
Tel-Aviv, Soraski Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ultrasound Unit in OBGYN, Soraski Medical Center
Tel Aviv, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Yoseph Hartoov, Dr
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TASMC-10-YH-0128-CTIL
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.